Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer
Author:
Zhao Jie,
Wang LuORCID,
Zhou Anda,
Wen Shidi,
Fang Wenfeng,
Zhang Li,
Duan Jianchun,
Bai Hua,
Zhong Jia,
Wan Rui,
Sun Boyang,
Zhuang Wei,
Lin Yiwen,
He Danming,
Cui Lina,
Wang Zhijie,
Wang Jie